Financier | Commitments |
---|---|
Borrower/Recipient | 4.30 |
IDA Credit | 15.00 |
P164164
Closed
Ana Besarabic
Republic of Djibouti
April 2, 2018
(as of board presentation)
July 9, 2018
February 26, 2019
US$ 19.30 million
Ministry of Health
2019
US$ 15.00 million
B
January 22, 2024
July 15, 2023
Yes
BANK APPROVED
Financier | Commitments |
---|---|
Borrower/Recipient | 4.30 |
IDA Credit | 15.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 15.00 |
IBRD + IDA Commitment | 15.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 19.30 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Apr 7, 2023 | IDA-62900 | Loan Disb | 488,150.40 |
Feb 21, 2023 | IDA-62900 | Int Charges | 42,042.29 |
Feb 21, 2023 | IDA-62900 | Int Charges | 42,042.29 |
Jan 15, 2023 | IDA-62900 | Int Charges | 209.84 |
Jan 15, 2023 | IDA-62900 | Int Charges | 209.84 |
Jan 11, 2023 | IDA-62900 | Loan Disb | 130,000.00 |
Jan 15, 2021 | IDA-62900 | Int Charges | 40.00 |
Jan 15, 2021 | IDA-62900 | Int Charges | 40.00 |
Jan 15, 2021 | IDA-62900 | Int Charges | 17,819.13 |
Jan 15, 2021 | IDA-62900 | Int Charges | 17,819.13 |
Jan 15, 2021 | IDA-62900 | Loan Disb | 657,486.60 |
Jul 15, 2021 | IDA-62900 | Int Charges | 256.03 |
Jul 15, 2021 | IDA-62900 | Int Charges | 256.03 |
Jul 15, 2021 | IDA-62900 | Int Charges | 27,253.13 |
Jul 15, 2021 | IDA-62900 | Int Charges | 27,253.13 |
May 6, 2021 | IDA-62900 | Loan Disb | 4,019,278.80 |
Nov 3, 2021 | IDA-62900 | Loan Disb | 1,314,973.20 |
May 17, 2022 | IDA-62900 | Loan Disb | -1,898.87 |
May 9, 2022 | IDA-62900 | Loan Disb | 669,879.80 |
Mar 17, 2022 | IDA-62900 | Loan Disb | 415,863.00 |
Feb 26, 2020 | IDA-62900 | Loan Disb | 650,000.00 |
Jul 28, 2020 | IDA-62900 | Loan Disb | 4,350,000.00 |
Jul 16, 2020 | IDA-62900 | Int Charges | 1,871.65 |
Jul 16, 2020 | IDA-62900 | Int Charges | 1,871.65 |
Aug 2, 2022 | IDA-62900 | Int Charges | 40,079.69 |
Jan 27, 2022 | IDA-62900 | Int Charges | 37,330.78 |
Jan 27, 2022 | IDA-62900 | Int Charges | 37,330.78 |
Dec 21, 2022 | IDA-62900 | Loan Disb | 150,000.00 |
Feb 13, 2024 | IDA-62900 | Int Charges | 756.59 |
Feb 13, 2024 | IDA-62900 | Int Charges | 756.59 |
Feb 13, 2024 | IDA-62900 | Int Charges | 50,367.17 |
Feb 13, 2024 | IDA-62900 | Int Charges | 50,367.17 |
Jul 15, 2024 | IDA-62900 | Int Charges | 17.75 |
Jul 15, 2024 | IDA-62900 | Int Charges | 17.75 |
Jul 9, 2018 | IDA-62900 | Loan Commitment | 15,000,000.00 |
Jul 15, 2023 | IDA-62900 | Int Charges | 675.37 |
Jul 15, 2023 | IDA-62900 | Int Charges | 675.37 |
Jul 15, 2023 | IDA-62900 | Int Charges | 45,150.42 |
Jul 15, 2023 | IDA-62900 | Int Charges | 45,150.42 |
Jun 30, 2023 | IDA-62900 | Loan Disb | 732,232.60 |
Jun 13, 2023 | IDA-62900 | Loan Disb | 200,000.02 |
Oct 25, 2023 | IDA-62900 | Loan Disb | 873,325.06 |
Jul 24, 2024 | IDA-62900 | Int Charges | 52,087.97 |
Jul 24, 2024 | IDA-62900 | Int Charges | 52,087.97 |
Jul 15, 2022 | IDA-62900 | Int Charges | 345.09 |
Jul 15, 2022 | IDA-62900 | Int Charges | 345.09 |
Jan 15, 2022 | IDA-62900 | Int Charges | 272.65 |
Jan 15, 2022 | IDA-62900 | Int Charges | 272.65 |
Aug 2, 2022 | IDA-62900 | Int Charges | 40,079.69 |
Name | Review | Date |
---|---|---|
Progress towards achievement of PDO | Moderately Satisfactory | 2023-07-22 |
Procurement | Satisfactory | 2023-07-22 |
Project Management | Satisfactory | 2023-07-22 |
Financial Management | Moderately Satisfactory | 2023-07-22 |
Monitoring and Evaluation | Satisfactory | 2023-07-22 |
Overall Implementation Progress (IP) | Satisfactory | 2023-07-22 |
Counterpart Funding | Satisfactory | 2023-07-22 |
INDICATOR | IMPLEMENTATION COMPLETION & RESULTS REPORT: 01-22-2024 |
---|---|
Outcomes | Moderately Satisfactory |
Risk to Development Outcome | |
Bank Performance | Moderately Satisfactory |
Borrower Performance | |
Government Performance | |
Implementing Agency |
INDICATOR | ICR REVIEW: 08-01-2024 | PROJECT PERFORMANCE ASSESSMENT REPORT: |
---|---|---|
Outcome Rating | Moderately Satisfactory | N/a |
Risk To Development Outcome | N/a | |
Bank Performance | Moderately Satisfactory | N/a |
Borrower Performance | N/a | |
Government Performance | N/a | |
Implementing Agency | N/a | |
Icr Quality | Substantial | N/a |
M&e Quality | Modest | N/a |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Infants 0-5 months exclusively breastfed | Value | 51.50 | 0.00 | 70.00 |
Date | April 30, 2019 | April 30, 2023 | December 29, 2023 | |
Comment |
Number of COVID-19 patients treated according to the MoH procedures | Value | 5323.00 | 6000.00 | 6000.00 |
Date | December 31, 2020 | December 29, 2023 | December 31, 2022 | |
Comment |
Number of health facilities receiving consumables, medicines and equipment financed by the project | Value | 0.00 | 20.00 | 20.00 |
Date | April 30, 2020 | December 29, 2023 | December 31, 2022 | |
Comment |
Women who attended at least four antenatal care visits during their most recent pregnancy | Value | 23.00 | 50.00 | 35.00 |
Date | December 31, 2012 | December 29, 2023 | ||
Comment |
Area sprayed to control locusts | Value | 0.00 | 2500.00 | 2500.00 |
Date | January 31, 2020 | December 29, 2023 | December 31, 2022 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Women referred by CHWs and registered at the health facility within 4 months of pregnancy (DLI 1A) | Value | 0.00 | 29618.00 | 3375.00 |
Date | March 31, 2018 | April 30, 2023 | December 29, 2023 | |
Comment |
A multi-sectoral nutrition coordinating mechanism is in place (DLI 2) | Value | No | Yes | Roadmap validated and action plan ratified by rele |
Date | March 31, 2018 | December 29, 2023 | December 31, 2022 | |
Comment |
Number of households having benefited from sensitization on hygiene, drinking water, good storage and handling practices of water at home | Value | 0.00 | 600.00 | 600.00 |
Date | April 30, 2020 | December 29, 2023 | December 31, 2022 | |
Comment |
Women referred by CHWs, who completed at least 3 antenatal visits at the health facility (DLI 1B) | Value | 0.00 | 19906.00 | 3800.00 |
Date | March 31, 2018 | April 30, 2023 | December 29, 2023 | |
Comment |
Number of PCR tests conducted for COVID-19 | Value | 0.00 | 200000.00 | 180000.00 |
Date | April 30, 2020 | December 29, 2023 | December 31, 2022 | |
Comment |
Women referred by CHWs, who completed at least 2 postnatal visits at the health facility (DLI 1C) | Value | 0.00 | 5696.00 | 2375.00 |
Date | March 31, 2018 | April 30, 2023 | December 29, 2023 | |
Comment |
Number of health facilities with intensive care units rehabilitated and equipped | Value | 0.00 | 3.00 | 2.00 |
Date | April 30, 2020 | December 29, 2023 | December 31, 2022 | |
Comment |
Percentage of grievances that are addressed and responded to within a timeline that has been specified and publicly communicated bythe project | Value | 0.00 | 60.00 | 50.00 |
Date | November 30, 2020 | December 29, 2023 | December 31, 2022 | |
Comment |
Percentage of children 6-23 months having received micronutrient powder supplement | Value | 32.00 | 61.00 | 60.00 |
Date | December 31, 2016 | April 30, 2023 | December 29, 2023 | |
Comment |
People who have received essential health, nutrition, and population (HNP) services | Value | 0.00 | 115821.00 | 75000.00 |
Date | March 31, 2018 | April 30, 2023 | December 29, 2023 | |
Comment |
People who have received essential health, nutrition, and population (HNP) services - Female (RMS requirement) | Value | 0.00 | 0.00 | 25000.00 |
Date | March 31, 2018 | September 27, 2018 | December 31, 2022 | |
Comment |
Number of women and children who have received basic nutrition services | Value | 0.00 | 115821.00 | 75000.00 |
Date | March 31, 2018 | April 30, 2023 | December 29, 2023 | |
Comment |
Number of health structures with a waste management system within the framework of the project | Value | 0.00 | 70.00 | 60.00 |
Date | April 30, 2020 | December 29, 2023 | December 31, 2022 | |
Comment |